These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 10764320

  • 21. Posttransplant lymphoproliferative disorder in pediatric renal transplantation.
    Srivastava T, Zwick DL, Rothberg PG, Warady BA.
    Pediatr Nephrol; 1999 Nov; 13(9):748-54. PubMed ID: 10603113
    [Abstract] [Full Text] [Related]

  • 22. Posttransplant lymphoproliferative disorders in transplant recipients.
    Timurağaoğlu A, Uğur-Bilgin A, Colak D, Tuncer M, Gölbaşi I, Hazar V, Kiliçarsłan B, Undar L, Demirbaş A.
    Transplant Proc; 2006 Mar; 38(2):641-5. PubMed ID: 16549195
    [Abstract] [Full Text] [Related]

  • 23. Sinonasal posttransplant lymphoproliferative disorder in pediatric lung transplant patients.
    Herrmann BW, Sweet SC, Molter DW.
    Otolaryngol Head Neck Surg; 2005 Jul; 133(1):38-41. PubMed ID: 16025050
    [Abstract] [Full Text] [Related]

  • 24. Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients.
    Sampaio MS, Cho YW, Shah T, Bunnapradist S, Hutchinson IV.
    Nephrol Dial Transplant; 2012 Jul; 27(7):2971-9. PubMed ID: 22273720
    [Abstract] [Full Text] [Related]

  • 25. Increased risk for posttransplant lymphoproliferative disease in recipients of liver transplants with hepatitis C.
    McLaughlin K, Wajstaub S, Marotta P, Adams P, Grant DR, Wall WJ, Jevnikar AM, Rizkalla KS.
    Liver Transpl; 2000 Sep; 6(5):570-4. PubMed ID: 10980055
    [Abstract] [Full Text] [Related]

  • 26. Lung retransplantation after posttransplantation lymphoproliferative disorder (PTLD): a single-center experience and review of literature of PTLD in lung transplant recipients.
    Raj R, Frost AE.
    J Heart Lung Transplant; 2005 Jun; 24(6):671-9. PubMed ID: 15949726
    [Abstract] [Full Text] [Related]

  • 27. Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naïve lung transplant recipient.
    Aris RM, Maia DM, Neuringer IP, Gott K, Kiley S, Gertis K, Handy J.
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1712-7. PubMed ID: 8970360
    [Abstract] [Full Text] [Related]

  • 28. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].
    Franco A, Jiménez L, Aranda I, Alvarez L, González M, Rocamora N, Olivares J.
    Nefrologia; 2002 Dec; 22(5):463-9. PubMed ID: 12497748
    [Abstract] [Full Text] [Related]

  • 29. Posttransplantation lymphoproliferative disorder in pediatric liver transplantation.
    Heo JS, Park JW, Lee KW, Lee SK, Joh JW, Kim SJ, Lee HH, Lee DS, Choi SH, Seo JM, Choe YH.
    Transplant Proc; 2004 Oct; 36(8):2307-8. PubMed ID: 15561231
    [Abstract] [Full Text] [Related]

  • 30. Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoroliferative disorder in adult renal allograft recipients.
    Shahinian VB, Muirhead N, Jevnikar AM, Leckie SH, Khakhar AK, Luke PP, Rizkalla KS, Hollomby DJ, House AA.
    Transplantation; 2003 Mar 27; 75(6):851-6. PubMed ID: 12660514
    [Abstract] [Full Text] [Related]

  • 31. Posttransplant lymphoproliferative disorder in pediatric liver transplantation.
    Uribe M, Hunter B, Alba A, Calabrán L, Flores L, Soto P, Herzog C.
    Transplant Proc; 2009 Mar 27; 41(6):2679-81. PubMed ID: 19716000
    [Abstract] [Full Text] [Related]

  • 32. Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se?
    Birkeland SA, Hamilton-Dutoit S.
    Transplantation; 2003 Sep 27; 76(6):984-8. PubMed ID: 14508366
    [Abstract] [Full Text] [Related]

  • 33. Impact of immunosuppression on the development of Epstein-Barr virus (EBV) viremia after pediatric liver transplantation.
    Lu BR, Park KT, Hurwitz M, Cox KL, Berquist WE.
    Transplant Proc; 2013 Sep 27; 45(1):301-4. PubMed ID: 23267800
    [Abstract] [Full Text] [Related]

  • 34. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations.
    Walker RC, Paya CV, Marshall WF, Strickler JG, Wiesner RH, Velosa JA, Habermann TM, Daly RC, McGregor CG.
    J Heart Lung Transplant; 1995 Sep 27; 14(2):214-21. PubMed ID: 7779838
    [Abstract] [Full Text] [Related]

  • 35. The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation.
    Sundin M, Le Blanc K, Ringdén O, Barkholt L, Omazic B, Lergin C, Levitsky V, Remberger M.
    Haematologica; 2006 Aug 27; 91(8):1059-67. PubMed ID: 16885046
    [Abstract] [Full Text] [Related]

  • 36. Timing of Epstein-Barr virus acquisition and the course of posttransplantation lymphoproliferative disorder in children.
    Wu JF, Ho MC, Ni YH, Chen HL, Lu CY, Hsu HY, Lee PH, Chang MH.
    Transplantation; 2009 Mar 15; 87(5):758-62. PubMed ID: 19295323
    [Abstract] [Full Text] [Related]

  • 37. Posttransplant lymphoproliferative disorder following pancreas transplantation.
    Issa N, Amer H, Dean PG, Kremers WK, Kudva YC, Rostambeigi N, Cosio FG, Larson TS, Habermann TM, Stegall MD, Griffin MD.
    Am J Transplant; 2009 Aug 15; 9(8):1894-902. PubMed ID: 19519812
    [Abstract] [Full Text] [Related]

  • 38. Post-transplant lymphoproliferative disorder after lung transplantation: a review of 35 cases.
    Kremer BE, Reshef R, Misleh JG, Christie JD, Ahya VN, Blumenthal NP, Kotloff RM, Hadjiliadis D, Stadtmauer EA, Schuster SJ, Tsai DE.
    J Heart Lung Transplant; 2012 Mar 15; 31(3):296-304. PubMed ID: 22112992
    [Abstract] [Full Text] [Related]

  • 39. Development of lymphoproliferative disease after liver transplantation.
    Marqués E, Jiménez C, Manrique A, Vallejo GH, Clemares M, Ortega P, Moreno E.
    Transplant Proc; 2008 Nov 15; 40(9):2988-9. PubMed ID: 19010169
    [Abstract] [Full Text] [Related]

  • 40. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M, Badwal S, Pandey R, Srivastava A, Sharma RK, Gupta RK.
    Clin Transplant; 2005 Oct 15; 19(5):668-73. PubMed ID: 16146560
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.